N4 Pharma. N4 Pharma Announces Collaboration with SRI to Target and Treat Cells in the Human Body that Have Been Previously Unreachable. Press Release. Apr. 25, 2024.

The majority of PMCs/PMRs are proceeding according to schedule. The FDA has released its annual Report on the Performance of Drugs and Biologics Firms in Conducting Postmarketing Requirements (PMRs) ...

Mary Van Gaasbeck, technical services specialist, LS Equipment and Services, at STERIS Life Sciences, notes that automation ...

Andreas Frerix, product management director for Quattroflow at PSG Biotech, discussed the advantages and new challenges SUTs ...

Pharmaceutical Technology® spoke with Nicole Hunter, Watson-Marlow Fluid Technology Solutions’ head of Global WMArchitect, ...

Susan Schniepp, distinguished fellow, Regulatory Compliance Associates, and co-chair of board of directors, Parenteral Drug ...

Developing freeze-drying processes requires patience and deep product and process understanding. Messenger RNA (mRNA) molecules are inherently unstable and readily degrade when exposed to ubiquitous ...

Engineering & Product Management for Malema at PSG Biotech, shared insights at on how current industry trends are shaping the ...

FDA has granted approval for the use of Novartis’ radioligand therapy, Lutathera, to treat pediatric patients with gastroenteropancreatic neuroendocrine tumors. Novartis announced, in an April 23, ...

Bob Hughes (Sr. Principal Scientist, Grace) and Brian Graves (Global Business Manager, Fine Chemicals, Grace) explain how Grace's experience as a CDMO can help customers from the lab to full-scale ...

At INTERPHEX, Bill Whitford, Strategic Solutions leader at Arcadis, discusses the progress made in 3D bioprinting toward ...